Cocrystal structure of meningococcal factor H binding protein variant 3 reveals a new crossprotective epitope recognized by human mAb 1E6

The 4 component meningococcus B vaccine (4CMenB) vaccine is the first vaccine containing recombinant proteins licensed for the prevention of invasive meningococcal disease caused by meningococcal serogroup B strains. 4CMenB contains 3 main recombinant proteins, including the Neisseria meningitidis f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:FASEB J
Päätekijät: Bianchi, Federica, Veggi, Daniele, Santini, Laura, Buricchi, Francesca, Bartolini, Erika, Lo Surdo, Paola, Martinelli, Manuele, Finco, Oretta, Masignani, Vega, Bottomley, Matthew J., Maione, Domenico, Cozzi, Roberta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Federation of American Societies for Experimental Biology 2019
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6902690/
https://ncbi.nlm.nih.gov/pubmed/31442074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1096/fj.201900374R
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia